Back

Atrial fibrillation burden according to genetic risk: a secondary analysis of the randomised LOOP study

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation nonmodifiable risk factors Genetic Causes EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Jonas Alexander Baadsgaard

The Heart Centre, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Creating a pipeline to extract genetic variants associated with atrial fibrillation to use in large, multi-ethnic management registries
Ms E. Dave (Downers Grove, US)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation in adults under 40 years: clinical profile, management strategies, and long-term outcomes after catheter ablation
Doctor A. Bakytzhanuly (Astana, KZ)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation on the prevalence and characteristics of cytopenia and clonal cytopenia of undetermined significance
Ms C. Forner (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Sex differences after atrial fibrillation ablation: a patient level meta-analysis
Mr L. Barbosa (Belo Horizonte, BR)
Abstract Slides Video
Presentation thumbnail
Catheter ablation for atrial fibrillation in patients with cardiac amyloidosis - Clinical characteristics and outcomes
Mrs M. Mronz (Cologne, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation nonmodifiable risk factors

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Association between polygenic risk score for atrial fibrillation and mortality in patients with chronic heart failure
thumbnail
Congress Presentation
Sequencing in over 120,000 cases unveils the rare coding variant architecture of atrial fibrillation
thumbnail
Congress Session
Registries on atrial fibrillation and sudden death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources